A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on how microorganisms within the nose can contribute to Alzheimer’s disease.
Calls for more study to be conducted into how microorganisms contribute to the onset and progression of Alzheimer’s disease.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
Griffith University researchers have demonstrated that a bacteria can travel through the olfactory nerve in the nose and into the brain in mice, where it creates markers that are a tell-tale sign of Alzheimer’s disease.
A bacterium commonly present in the nose can sneak into the brain and may increase the risk of Alzheimer’s disease.
An Australian-first rehabilitation trial considered the next crucial step in treating paralysis will proceed after a record donation from the country’s leading spinal injury research foundation.